Search

Cancer screenings are essential. MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared why cancer care screenings are critical during an interview with PBS Metrofocus.

… Friday, August 14, 2020 It’s time to go back. Cancer care is essential care and screenings and treatments can’t wait. That was the message that MSK’s Physician-In-Chief and Chief Medical Officer, Lisa DeAngelis, MD, shared during a recent interview with  PBS Metrofocus .  When COVD-19 first hit the tri-state

The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade.

… Friday, March 1, 2019 The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade. To understand the impact of this, and other recent changes, we staged patients using our extensive, prospectively collected database at Memorial Sloan Kettering

In February, Harold Varmus' memoir about his life in science was published.

… Sunday, March 1, 2009 Summary In February, Harold Varmus’ memoir about his life in science was published. The Art and Politics of Science, Harold Varmus In February, W. W. Norton & Company published Memorial Sloan Kettering Cancer Center President Harold Varmus’ memoir about his life in science. The

GSK's Third Biennial Retreat, April 25-26, will feature clinician-scientist Todd R. Golub in Skytop, Pennsylvania.

… Tuesday, April 22, 2014 The Gerstner Sloan Kettering Graduate School of Biomedical Sciences’ (GSK) Third Biennial Retreat will take place from April 25–26 at Skytop Lodge in Skytop, Pennsylvania. The retreat will feature clinician-scientist Todd R. Golub as the keynote speaker. A founding director and

… Tuesday, May 5, 2026 Semanti Mukherjee Awarded Chairman’s Prize Third-year student Semanti Mukherjee was awarded the Chairman’s Prize for her first-author paper In vitro mammalian cytotoxicological study of PAMAM dendrimers -towards quantitative structure activity relationships, published March 2009

Learn how a heralded clinical trial that made rectal cancer disappear for every participant is being expanded at Memorial Sloan Kettering Cancer Center. The trial uses only immunotherapy that targets a rare mutation — without the need for surgery, chemotherapy, or radiation.

… Wednesday, August 16, 2023 “I’d always dreamed of having a huge family.” For Kelly Spill, learning she had rectal cancer didn’t only mean facing a potentially life-threatening disease. The diagnosis also threatened many of the things she held dearest in life. Kelly was diagnosed at 28, just months after

A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.

… Wednesday, June 27, 2018 Summary Drug resistance is when a tumor stops responding to a targeted therapy. It is a serious problem in cancer treatment. Now, a multidisciplinary team has discovered a previously unknown mechanism of resistance to a new leukemia drug. Last summer, the US Food and Drug Administration

There is very little evidence that drinking hot beverages increases esophageal cancer risk.

… Thursday, August 4, 2022 Note: This story was originally published in 2019 and has been updated. It seems that almost every dietary habit has at some point been linked to an increased risk of cancer. In recent years, the idea has emerged that drinking very hot beverages like coffee and tea could contribute

New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.

… Thursday, May 18, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating

Direna Alonso-Curbelo, PhD, of Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), has been named a winner of the 2021 Blavatnik Regional Awards for Young Scientists in the “Life Sciences” category.

… Wednesday, September 22, 2021 Direna Alonso-Curbelo, PhD , of Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), has been named a winner of the 2021 Blavatnik Regional Awards for Young Scientists in the “Life Sciences” category. Honoring outstanding postdoctoral scientists